Research Focus

Former Employee. Molecular Pharmacology Program; Vacation Relief

Recent additions – View all

1. High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML

   Meeting Abstract

   Maslak, P.; Weiss, M.; Jurcic, J.; Jimenez, J.; Berman, E.; Golde, D.; Scheinberg, D.
   Blood (1998)

   Fulltext@MSK | Save